Back

The Drug-Induced Respiratory Disease Website and App

XII.g

XII - Cardiovascular involvement / toxicity

Coronary artery disease (acute) - Myocardial ischemia/infarction

Last update 17/06/2026

Including acute coronary artery disease or spasm and acute ST segment elevation on ECG/EKG. See also under Xg, XIIo and XIIaf

Causative drugs

60

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

Abused drugs/substances (illicit-, street drugs - IV/inhaled)
I.c
I.e
I.j
I.m
I.s
I.t
II.a
II.b
III.a
IV.a
IV.f
IV.g
V.f
V.q
V.ab
VI.b
VI.c
VI.g
VI.i
VI.j
VI.r
VI.t
VII.h
VII.i
VIII.c
VIII.d
VIII.ai
IX.a
IX.s
IX.ah
X.m
X.u
X.ac
X.bb
XI.b
XI.g
XI.j
XI.n
XII.g
XII.i
XII.v
XV.q
XV.s
XV.v
XV.ag
XV.al
XVI.d
XVI.u
XVI.v
XVI.ab
XVI.ae
XVI.af
XVI.ai
XVII.a
XVII.b
XVII.g
XVII.p
XVII.s
XVII.u
XVII.al
XVIII.t
XVIII.u
XVIII.x
Acetylcholine
XII.g
Adrenaline (epinephrine)
II.a
II.d
II.i
XI.b
XI.d
XII.e
XII.f
XII.g
XII.j
XII.l
XII.t
XII.w
XII.af
XII.aq
Anabolic androgenic steroids
I.j
I.n
II.b
II.d
II.f
III.a
IV.x
VI.e
X.u
XII.a
XII.c
XII.f
XII.g
XII.l
XII.o
XII.v
XII.ai
XV.n
XV.p
XV.bu
Beta2 agonists (inhaled)
II.a
IV.a
VIII.d
VIII.e
XI.y
XII.g
XII.l
Bevacizumab
I.b
II.b
III.a
III.c
III.g
III.h
III.k
IV.a
V.f
VI.a
VI.b
VIII.o
VIII.r
VIII.ab
X.f
X.s
XI.s
XII.a
XII.e
XII.f
XII.g
XII.ai
XII.aj
XII.at
XVI.ab
XVI.af
XVI.bf
XXVII.f
Bupropion, bupropion poisoning
VIII.a
X.a
X.p
XII.g
XII.l
XII.ah
Caffeine
II.a
II.d
XI.n
XII.g
XII.l
XII.n
Cannabinoids - Cannabinoid receptor agonists (synthetic) (K2, Spice)
I.a
I.c
I.e
I.ao
II.a
II.b
II.v
III.a
III.c
III.m
VI.a
VII.h
VIII.b
IX.d
X.u
X.ba
XI.b
XI.g
XI.n
XI.w
XI.bl
XII.g
XII.l
XII.aj
Capecitabine
I.b
I.m
VII.a
VIII.af
X.k
XI.b
XII.d
XII.g
XII.af
XII.ai
Carbon monoxide (CO)
II.a
II.b
VI.a
IX.t
X.c
XI.n
XII.f
XII.g
XII.af
XIV.c
XIV.f
XV.w
Catheter ablation for atrial fibrillation
I.b
I.y
I.ao
II.b
III.a
III.c
III.h
III.l
IV.d
IV.z
IV.ah
V.a
V.e
V.n
VI.b
VI.o
VI.z
VI.ac
VI.ae
VII.d
VII.g
VII.h
VIII.b
VIII.h
VIII.j
IX.j
IX.n
XI.b
XI.h
XII.c
XII.g
XII.y
XII.af
XII.aw
XII.bd
XII.bg
XII.bh
XII.bk
XII.ca
XV.g
XV.ah
XV.ak
XV.cx
XVI.b
XVI.l
XVI.bg
XVI.bo
XVII.a
XXVII.a
Chemotherapy, antineoplastic
I.a
I.b
I.c
I.d
I.f
I.g
I.h
I.k
I.l
I.m
I.n
I.v
I.w
I.x
I.y
I.aa
I.ad
I.ao
I.au
II.a
II.b
II.c
II.d
III.a
IV.a
IV.k
V.a
V.f
V.ab
VI.b
VI.c
VI.f
VII.a
VII.h
VIII.a
VIII.t
IX.f
IX.j
IX.o
X.c
X.d
X.f
X.g
X.k
X.n
XI.b
XI.k
XI.s
XII.a
XII.b
XII.c
XII.e
XII.f
XII.g
XII.l
XII.s
XII.ai
XII.bl
XIII.a
XIII.b
XIII.d
XV.c
XV.d
XV.f
XV.i
XV.l
XV.ak
XV.am
XV.ba
XVI.ab
XVI.af
XVI.bf
XVI.bl
XVI.bw
XVII.b
XVII.c
XVII.e
XVII.g
XVII.j
XVII.r
XVII.af
XIX.g
Clarithromycin
I.c
IV.a
X.h
XII.g
Clomifen
II.a
III.a
III.c
III.i
V.a
V.g
VI.a
XII.g
Loading more…